Screening Strategy for Early Diagnosis of Silicosis in At-Risk Populations in Oklahoma
1 other identifier
observational
183
1 country
1
Brief Summary
Silicosis, a preventable yet irreversible occupational lung disease, has an insidious onset with a latency period for diagnosis extending beyond 10 years from the initial exposure. The central hypothesis of this study is that silicosis cases may currently be going undetected. The long-term goal of this research is to determine the current prevalence and forecast the future prevalence of silicosis and other pneumoconiosis among working populations in Oklahoma and to assist the public health and the healthcare system in planning for a potential resurgence of silicosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2019
CompletedFirst Submitted
Initial submission to the registry
November 19, 2019
CompletedFirst Posted
Study publicly available on registry
December 19, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 10, 2022
CompletedDecember 6, 2023
December 1, 2023
2.1 years
November 19, 2019
December 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Estimate of average cumulative respirable crystalline silica exposure (semi-quantitative)
Single point assessment at baseline survey
Percentage of participants who report any exposure to silica
Percentage of participants who report any exposure to silica
Single point assessment at baseline survey
Prevalence of silicosis among study group
Percentage of participants with confirmed diagnosis of silicosis
Single point assessment at clinic visit
Secondary Outcomes (1)
Analysis to determine if any demographic, work history, or other trait correlates with increased silica exposure
Single point assessment at baseline survey
Interventions
Tuberculosis (TB) test: A blood sample is collected for lab testing to determine if you have tuberculosis (QuantiFeron test). Alternatively, the test is done by injecting a small amount of fluid (called tuberculin) into the skin on the lower part of the arm. A person given the tuberculin skin test must return within 48 to 72 hours to have a trained health care worker look for a reaction on the arm.
Chest X ray: non-invasive medical test that helps physicians diagnose and treat medical conditions of the lungs and chest. The Chest X-ray will be done to check for abnormalities on the lungs. The test is non-invasive.
A pulmonary function test (PFT, spirometry) is a breathing test that measures how much air your lungs can hold as well as how hard and fast you can blow air out of your lungs. The test is not invasive and involves blowing into a machine.
Eligibility Criteria
Primary care clinic, community sample Participants will be recruited from waiting rooms or other common spaces at participating community health clinics.
You may qualify if:
- Male 30 years or older
- Past or present employment in dusty environment, exposed to dust at work
- Ability to consent and answer the questionnaire
You may not qualify if:
- Female
- Never exposed to dusty environment or never exposed to dust at work
- Inability to consent and answer the questionnaire
- Age 29 years or younger
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jad Kebbe, MD
University of Oklahoma
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2019
First Posted
December 19, 2019
Study Start
January 14, 2019
Primary Completion
February 24, 2021
Study Completion
June 10, 2022
Last Updated
December 6, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 2 years after publication
- Access Criteria
- Active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center
Researchers may request a deidentified dataset. The de-identified dataset may be shared between other investigators of the same institution as the PI, in accordance with University and Institutional Review Board policies. Any investigator not affiliated with the University of Oklahoma Health Sciences Center who desires access to a de-identified dataset may do so by coordinating a Data Use Agreement between the investigator's institution and the PI's institution. Datasets will only be released with an active Data Use Agreement or other similar agreement with the University of Oklahoma Health Sciences Center.